ENGINEERING A CONTROL DRUG RELEASE PROFILE VIA LIPOSOME COMPOSITION IN BOTH AQUEOUS ANDNON-AQUEOUS COMPARTMENTS

• 收藏
• 分享

专利权人:

TLC BIOPHARMACEUTICALS, INC.;TAIWAN LIPOSOME COMPANY; LTD.;TAIWAN LIPOSOME COMPANY, LTD.

发明人:

KAN, PEI,TSENG, YUN-LONG,OU, HAN, CHUN

申请号：

SG11201507110W

公开号：

SG11201507110WA

申请日:

2014.03.15

申请国别(地区):

SG

年份:

2015

代理人:

摘要：

The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/